Yunnan Watson Biotech announced the revised draft plan for issuing A shares to specific objects in 2026. The plan was approved by the board of directors and will be submitted for shareholder approval. The disclosure does not represent approval from regulatory bodies, and the issuance is subject to further approvals.
Summary generated by AI · Always verify with source document
Stock Code: 300142 Stock Abbreviation: Watson Bio Announcement No.: 2026-065
Yunnan Watson Biotech Co., Ltd.
Announcement on Disclosure of the Revised Draft Plan for Issuance of A Shares to Specific Objects in 2026
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, without any false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.